Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Topical ruxolitinib quickly improves non-segmental vitiligo.

ICMR created standard treatment guidelines for skin diseases to improve care across India.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

Early recognition of symptoms is crucial for treating IPEX syndrome with a stem cell transplant.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

More research is needed to understand sex and racial differences in long COVID.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

TMPRSS2 affects COVID-19 severity and treatment options.

Cadd4 effectively reduces cholesterol levels without side effects.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

The boy's symptoms improved with vitamin C treatment, highlighting the need to consider scurvy in kids with unusual diets.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Chemical leukoderma is temporary, while chemical-induced vitiligo can be persistent and harder to treat.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.